In response to:

Don't Let Obama Kill "Pills for Profit"

hmiller Wrote: Jan 29, 2013 5:42 PM
Sir you wrote; " But, just like a wildcatter staking an oil claim, the profits are large for investors willing to be patient and work hard." What work do investors do? Sounds like do do to many; that's why they are referred to as parasites. Must be a heck of a minimum wage. Complete with write off's and the new, lower than workers, tax rate.
FletchforFreedom Wrote: Jan 29, 2013 5:50 PM
To someone with I higher IQ, I wouldn't have to say this: When I used the term "genius", I was being facetious.
Ron-CA Wrote: Jan 29, 2013 5:49 PM
Not all investors are passive, in many industries it is common for investors to be part of the team working on a project.
FletchforFreedom Wrote: Jan 29, 2013 5:49 PM
Look, genius, grow a brain or read an economics text. Investors have invested their labor in order to obtain the capital they invest. They then surrender that capital, foregoing its use, to another who uses it productively and benefits society tremendously.

Imbeciles referring to investors as "parasites" demonstrate an ignorance unparalleled. That kind of Marxian idiocy has been LONG debunked!
nawlins72 Wrote: Jan 29, 2013 5:53 PM
But Fletch....what about the "wage slaves"!!!
FletchforFreedom Wrote: Jan 29, 2013 5:55 PM
Good grief, man! This fool will think you're serious!!!
nawlins72 Wrote: Jan 29, 2013 5:49 PM
If you define "work" as "manual labor", then MANY people in the world don't "work". Investors work through the use of their knowledge of markets which assists them in making decisions concerning investment of capital. Who are they "parastizing"?

Biotech company Excelixis CEO George Scangos likes to quote oil wildcatter JP Getty when asked about his philosophy for success: “Get up early; work hard; find oil,” he deadpans.

And under the direction of dry-humored Scangos, the San Francisco-based company is drilling a lot of research holes, so to speak.

They have to: Success in the biotech industry is measured incrementally, not in big steps. It’s a cash-and-time intensive industry where success is painstaking, rare and, because of Obamacare and other regulatory burdens from the administration, likely to become even rarer.   

According to Plunkett Research, Ltd in 2010 it...

Related Tags: Obama